P
Per Rosenberg
Researcher at Linköping University
Publications - 81
Citations - 4782
Per Rosenberg is an academic researcher from Linköping University. The author has contributed to research in topics: Endometrial cancer & Carboplatin. The author has an hindex of 28, co-authored 80 publications receiving 3975 citations. Previous affiliations of Per Rosenberg include Geological Survey of Denmark and Greenland.
Papers
More filters
Journal ArticleDOI
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor Raza Mirza,Bradley J. Monk,Jørn Herrstedt,Amit M. Oza,Sven Mahner,Sven Mahner,Andrés Redondo,Michel Fabbro,Jonathan A. Ledermann,Domenica Lorusso,Ignace Vergote,Noa Ben-Baruch,Christian Marth,Radosław Mądry,René dePont Christensen,Jonathan S. Berek,Anne Dørum,Anne Dørum,Anna V. Tinker,Andreas du Bois,Antonio González-Martín,Philippe Follana,Benedict B. Benigno,Per Rosenberg,Lucy Gilbert,Bobbie J. Rimel,Joseph Buscema,John Balser,Shefali Agarwal,Ursula A. Matulonis,Ursula A. Matulonis +30 more
TL;DR: Among patients with platinum-sensitive, recurrent ovarian cancer, the median duration of progression-free survival was significantly longer amongThose receiving niraparib than among those receiving placebo, regardless of the presence or absence of gBRCA mutations or HRD status, with moderate bone marrow toxicity.
Journal ArticleDOI
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies
Thomas Högberg,Mauro Signorelli,Carlos Freire de Oliveira,Roldano Fossati,Andrea Lissoni,Bengt Sorbe,Håkan Andersson,Seija Grénman,Caroline Lundgren,Per Rosenberg,Karin Boman,Bengt Tholander,Giovanni Scambia,Nicholas S. Reed,Gennaro Cormio,Germana Tognon,Jackie Clarke,Thomasz Sawicki,Paolo Zola,Gunnar B. Kristensen +19 more
TL;DR: Addition of adjuvant chemotherapy to radiation improves progression-free survival in operated endometrial cancer patients with no residual tumour and a high-risk profile.
Journal ArticleDOI
Advanced epithelial ovarian cancer: 1998 consensus statements.
Jonathan S. Berek,Kamma Bertelsen,A. du Bois,Mark F. Brady,Joseph C. Carmichael,Elizabeth Eisenhauer,Martin Gore,Seija Grénman,Thomas C. Hamilton,Svein Hansen,Peter Harper,G. Horvath,S. B. Kaye,Hans Joachim Lück,Bente Lund,William McGuire,Jan P. Neijt,Robert F. Ozols,M. K. B. Parmar,Martine Piccart-Gebhart,R.E.N. van Rijswijk,Per Rosenberg,G. J.S. Rustin,C. Sessa,J.T. Thigpen,Claes G. Tropé,M. K. Tuxen,Ignace Vergote,Jan B. Vermorken,Phb Willemse +29 more
TL;DR: This article reports on the statements written by the chairmen and approved by the consensus group, which achieved consensus on a number of issues with implications for standard practice and for research.
Advanced epithelial ovarian cancer: 1998 Consensus statements
Jonathan S. Berek,Kamma Bertelsen,A. du Bois,Mark F. Brady,Joseph C. Carmichael,Elizabeth Eisenhauer,Martin Gore,Seija Grénman,Thomas C. Hamilton,Svein Hansen,Peter Harper,G. Horvath,S. B. Kaye,Hans Joachim Lück,Bente Lund,William McGuire,Jan P. Neijt,Robert F. Ozols,M. K. B. Parmar,Martine Piccart-Gebhart,R.E.N. van Rijswijk,Per Rosenberg,G. J.S. Rustin,C. Sessa,J.T. Thigpen,Claes G. Tropé,M. K. Tuxen,Ignace Vergote,Jan B. Vermorken,Phb Willemse +29 more
TL;DR: One of the major conclusions drawn by the consensus committee was that in previously untreated advanced ovarian cancer, cisplatin plus paclitaxel has been shown to be superior to previous standard therapy with cisPlatin plus cyclophosphamide (level I evidence).
Journal ArticleDOI
Oxygen groups in coals and alginite-rich kerogen revisited
TL;DR: In this article, a detailed Fourier Transform Infrared Spectroscopy (FTIR) analysis was applied to gain insight into the relative proportions and types of oxygen functional groups in coals of varying rank and in alginite-rich organic matter in oil shales and marine shale.